References
- Fotherby K. Oral contraceptives, lipids, and cardiovascular disease. Contraception 1985; 31: 367–94
- Gaspard U J. Metabolic effects of contraceptives. Am J Obstet Gynecol 1987; 157: 1029–41
- Miller G J., Miller N E. Plasma high-density lipoprotein concentration and development of ischemic heart disease. Lancet 1975; 1: 1618
- Chapdelaine A, Desmarais J L., Derman R J. Clinical evidence of the minimal androgenic activity of norgestimate. Int J Fertil 1989; 34: 347–52
- Corson S L. Efficacy and clinical profile of a new oral contraceptive containing norgestimate. US clinical trials. Acta Obstet Gynecol Scand Suppl 1990; 69: 25–31
- Becker H. Supportive European data on a new oral contraceptive containing norgestimate. Acta Obstet Gynecol Scand Suppl 1990; 69: 33–9
- Havel R J., Eder H A., Bragdon J H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–53
- Roschlau P, Bernt E, Gruber W. Enzymatische bestimmung des gesamtcholesterins im serum. Z Klin Chem Klin Biochem 1974; 12: 403
- Schettler G, Nussel E. Massnahmen zur pravention der arteriosklerose. Arbeitsmed Pratentiumed 1975; 10: 25
- Fievet-Desreumaux C, Dedonder-Decoopman E, Dewailly P, et al. Immunochemical determination of human apolipoprotein A1 by laser nephelometry. Clin Chim Acta 1980; 107: 145–8
- Fievet-Desreumaux C, Dedonder-Decoopman E, Fruchart J C., et al. Immunochemical determination of human apolipoprotein B by laser nephelometry. Clin Chim Acta 1979; 95: 405–8
- Egloff M, Vranckx R, Tardivel-Lacomb J, Degrelle H. Immunochemical characterization and quantitation of human sex steroid binding plasma protein. Steroids 1981; 37: 455
- Miller N E., Hammett F, Saltissi S, et al. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J 1981; 282: 1741–4
- Wynn V, Niththyananthan R. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. Am J Obstet Gynecol 1982; 142: 766–72
- Castelli W P., Doyle J T., Gordon T, et al. HDL cholesterol and other lipids in coronary heart disease. The Cooperative Lipoprotein Phenotyping Study. Circulation 1977; 55: 767–72
- Stampfer M J., Sacks F M., Salvini S, et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991; 325: 373–81
- Huttunen J K., Manninen V, Manttari M, et al. The Helsinki Heart Study: central findings and clinical implications. Ann Med 1991; 23: 155–9
- Longcope C, Hui S L., Johnston C C., Jr. Free estradiol, free testosterone, and sex hormone binding globulin in perimenopausal women. J Clin Endocrinol Metab 1987; 64: 513–8
- El Makhzangy M N., Wynn V, Lawrence D M. Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids. Clin Endocrinol 1979; 10: 39–45
- Phillips A, Hahn D W., McGuire J L. Preclinical evaluation of norgestimate. a progestin with minimal androgenic activity. Am J Obstet Gynecol 1991; 165: 1611